IMMUNOCELLULAR THERAPEUTICS's ticker is IMUC and the CUSIP is 452536105. A total of 37 filers reported holding IMMUNOCELLULAR THERAPEUTICS in Q3 2013. The put-call ratio across all filers is 2.40 and the average weighting 0.0%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Callan Capital, LLC | 70,000 | $180,000 | 0.09% |
| Ifrah Financial Services, Inc. | 28,500 | $73,000 | 0.04% |
| CHELSEA COUNSEL CO | 28,000 | $72,000 | 0.02% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 175,000 | $450,000 | 0.02% |
| Highlander Capital Management, LLC | 5,000 | $12,850,000 | 0.01% |
| GROUP ONE TRADING, L.P. | 154,815 | $398,000 | 0.01% |
| Gerstein Fisher | 10,000 | $26,000 | 0.01% |
| First Allied Advisory Services, Inc. | 40,000 | $103,000 | 0.01% |
| Wellington Shields Capital Management, LLC | 10,000 | $26,000 | 0.01% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 123,857 | $318,000 | 0.00% |